HealthInvest Partners AB as of Sept. 30, 2022
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 10 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Utah Medical Products (UTMD) | 15.5 | $7.3M | 86k | 85.31 | |
| Bristol Myers Squibb (BMY) | 14.7 | $7.0M | 98k | 71.09 | |
| Gilead Sciences (GILD) | 13.7 | $6.5M | 105k | 61.69 | |
| Cigna Corp (CI) | 10.0 | $4.7M | 17k | 277.47 | |
| Kempharm Com New (ZVRA) | 9.9 | $4.7M | 750k | 6.24 | |
| Cardinal Health (CAH) | 9.9 | $4.7M | 70k | 66.69 | |
| McKesson Corporation (MCK) | 9.3 | $4.4M | 13k | 339.85 | |
| Viatris (VTRS) | 8.6 | $4.1M | 480k | 8.52 | |
| Opiant Pharmaceuticals | 4.8 | $2.3M | 210k | 10.75 | |
| Aurinia Pharmaceuticals (AUPH) | 3.7 | $1.7M | 230k | 7.52 |
